Impact of Stress and Glucocorticoids on Schema-Based Learning

Standard

Impact of Stress and Glucocorticoids on Schema-Based Learning. / Kluen, Lisa Marieke; Nixon, Patricia; Agorastos, Agorastos; Wiedemann, Klaus; Schwabe, Lars.

In: NEUROPSYCHOPHARMACOL, Vol. 42, No. 6, 05.2017, p. 1254-1261.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kluen, LM, Nixon, P, Agorastos, A, Wiedemann, K & Schwabe, L 2017, 'Impact of Stress and Glucocorticoids on Schema-Based Learning', NEUROPSYCHOPHARMACOL, vol. 42, no. 6, pp. 1254-1261. https://doi.org/10.1038/npp.2016.256

APA

Vancouver

Bibtex

@article{29b10c30198944c8a6a9bd664434ac5c,
title = "Impact of Stress and Glucocorticoids on Schema-Based Learning",
abstract = "Pre-existing knowledge, a 'schema', facilitates the encoding, consolidation, and retrieval of schema-relevant information. Such schema-based memory is key to every form of education and provides intriguing insights into the integration of new information and prior knowledge. Stress is known to have a critical impact on memory processes, mainly through the action of glucocorticoids and catecholamines. However, whether stress and these major stress mediators affect schema-based learning is completely unknown. To address this question, we performed two experiments, in which participants acquired a schema on day 1 and learned schema-related as well as schema-unrelated information on day 2. In the first experiment, participants underwent a stress or control manipulation either immediately or about 25 min before schema-based memory testing. The second experiment tested whether glucocorticoid and/or noradrenergic activation is sufficient to modulate schema-based memory. To this end, participants received orally a placebo, hydrocortisone, the α2-adrenoceptor-antagonist yohimbine, leading to increased noradrenergic stimulation, or both drugs, before completing the schema-based memory test. Our data indicate that stress, irrespective of the exact timing of the stress exposure, impaired schema-based learning, while leaving learning of schema-unrelated information intact. A very similar effect was obtained after hydrocortisone, but not yohimbine, administration. These data show that stress disrupts participants' ability to benefit from prior knowledge during learning and that glucocorticoid activation is sufficient to produce this effect. Our findings provide novel insights into the impact of stress and stress hormones on the dynamics of human memory and have important practical implications, specifically for educational contexts.",
keywords = "Adrenergic alpha-2 Receptor Antagonists, Adult, Cognitive Dysfunction, Female, Glucocorticoids, Humans, Hydrocortisone, Learning, Male, Stress, Psychological, Yohimbine, Young Adult, Journal Article",
author = "Kluen, {Lisa Marieke} and Patricia Nixon and Agorastos Agorastos and Klaus Wiedemann and Lars Schwabe",
year = "2017",
month = may,
doi = "10.1038/npp.2016.256",
language = "English",
volume = "42",
pages = "1254--1261",
journal = "NEUROPSYCHOPHARMACOL",
issn = "0893-133X",
publisher = "NATURE PUBLISHING GROUP",
number = "6",

}

RIS

TY - JOUR

T1 - Impact of Stress and Glucocorticoids on Schema-Based Learning

AU - Kluen, Lisa Marieke

AU - Nixon, Patricia

AU - Agorastos, Agorastos

AU - Wiedemann, Klaus

AU - Schwabe, Lars

PY - 2017/5

Y1 - 2017/5

N2 - Pre-existing knowledge, a 'schema', facilitates the encoding, consolidation, and retrieval of schema-relevant information. Such schema-based memory is key to every form of education and provides intriguing insights into the integration of new information and prior knowledge. Stress is known to have a critical impact on memory processes, mainly through the action of glucocorticoids and catecholamines. However, whether stress and these major stress mediators affect schema-based learning is completely unknown. To address this question, we performed two experiments, in which participants acquired a schema on day 1 and learned schema-related as well as schema-unrelated information on day 2. In the first experiment, participants underwent a stress or control manipulation either immediately or about 25 min before schema-based memory testing. The second experiment tested whether glucocorticoid and/or noradrenergic activation is sufficient to modulate schema-based memory. To this end, participants received orally a placebo, hydrocortisone, the α2-adrenoceptor-antagonist yohimbine, leading to increased noradrenergic stimulation, or both drugs, before completing the schema-based memory test. Our data indicate that stress, irrespective of the exact timing of the stress exposure, impaired schema-based learning, while leaving learning of schema-unrelated information intact. A very similar effect was obtained after hydrocortisone, but not yohimbine, administration. These data show that stress disrupts participants' ability to benefit from prior knowledge during learning and that glucocorticoid activation is sufficient to produce this effect. Our findings provide novel insights into the impact of stress and stress hormones on the dynamics of human memory and have important practical implications, specifically for educational contexts.

AB - Pre-existing knowledge, a 'schema', facilitates the encoding, consolidation, and retrieval of schema-relevant information. Such schema-based memory is key to every form of education and provides intriguing insights into the integration of new information and prior knowledge. Stress is known to have a critical impact on memory processes, mainly through the action of glucocorticoids and catecholamines. However, whether stress and these major stress mediators affect schema-based learning is completely unknown. To address this question, we performed two experiments, in which participants acquired a schema on day 1 and learned schema-related as well as schema-unrelated information on day 2. In the first experiment, participants underwent a stress or control manipulation either immediately or about 25 min before schema-based memory testing. The second experiment tested whether glucocorticoid and/or noradrenergic activation is sufficient to modulate schema-based memory. To this end, participants received orally a placebo, hydrocortisone, the α2-adrenoceptor-antagonist yohimbine, leading to increased noradrenergic stimulation, or both drugs, before completing the schema-based memory test. Our data indicate that stress, irrespective of the exact timing of the stress exposure, impaired schema-based learning, while leaving learning of schema-unrelated information intact. A very similar effect was obtained after hydrocortisone, but not yohimbine, administration. These data show that stress disrupts participants' ability to benefit from prior knowledge during learning and that glucocorticoid activation is sufficient to produce this effect. Our findings provide novel insights into the impact of stress and stress hormones on the dynamics of human memory and have important practical implications, specifically for educational contexts.

KW - Adrenergic alpha-2 Receptor Antagonists

KW - Adult

KW - Cognitive Dysfunction

KW - Female

KW - Glucocorticoids

KW - Humans

KW - Hydrocortisone

KW - Learning

KW - Male

KW - Stress, Psychological

KW - Yohimbine

KW - Young Adult

KW - Journal Article

U2 - 10.1038/npp.2016.256

DO - 10.1038/npp.2016.256

M3 - SCORING: Journal article

C2 - 27841278

VL - 42

SP - 1254

EP - 1261

JO - NEUROPSYCHOPHARMACOL

JF - NEUROPSYCHOPHARMACOL

SN - 0893-133X

IS - 6

ER -